In addition to facilitating the progression and metastasis of cancer cells within the TME, TAMs also promote the survival of circulating tumor cells (CTCs) by activating the PI3K/Akt survival signaling pathway in cancer cells and secreting protective chemokines and cytokines [323,324,325]. Here, AKT1 is linked to cancer.